Management of Low Diastolic Blood Pressure in CHF Patients

Critical DBP Thresholds

• The European Society of Cardiology recommends avoiding further reduction of antihypertensive medications when DBP is already in the 50s to prevent compromised coronary perfusion 1
• Post-hoc analysis from the SHEP study specifically identified DBP below 70 mmHg, and especially below 60 mmHg, as a high-risk group with poorer outcomes in patients with cardiovascular disease 1

Special Considerations in CHF Patients

• Coronary perfusion occurs primarily during diastole, and CHF patients often have underlying coronary disease that makes them especially vulnerable to low diastolic pressures 1
• The Syst-Eur trial found evidence of harm from low DBP specifically in patients with pre-existing coronary heart disease, even when DBP was as high as 55 mmHg 1

Management Algorithm When DBP is Low

• Do not increase antihypertensive medications even if systolic BP is elevated when DBP is 50-60 mmHg 1
• Consider reducing or modifying the current antihypertensive regimen if it is causing excessive diastolic reduction when DBP is 50-60 mmHg 1
• Target systolic BP of 130-139 mmHg rather than more aggressive targets in elderly CHF patients when DBP is 60-70 mmHg 3, 1

Critical Pitfalls to Avoid

• Focusing exclusively on systolic BP targets can inadvertently drop DBP to dangerous levels, particularly in elderly patients with wide pulse pressure 1
• Dizziness, fatigue, or syncope may indicate DBP is too low and causing end-organ hypoperfusion 1

Medication Selection

• In CHF patients with low DBP, avoid medications that primarily lower diastolic pressure (such as dihydropyridine calcium channel blockers as monotherapy) 4, 5
• Prefer medications with proven mortality benefit in CHF (ACE inhibitors, ARBs, beta-blockers, aldosterone antagonists, diuretics) that can be carefully titrated 4, 5

Monitoring Requirements

• Check for orthostatic hypotension regularly, as CHF patients are particularly vulnerable to postural BP drops 1
• Monitor renal function and electrolytes when adjusting medications in the setting of low DBP 5
• Assess for symptoms of hypoperfusion at each visit, not just BP numbers 1
• Consider home BP monitoring to capture variability and avoid treatment decisions based on isolated readings 3